Endler, Citro, Pongratz, Smith, Vinattieri and Senekowitsch, Erfahrungsheilkunde, 1995. Two double blind trials in Austria and Italy, 468 tadpoles in the main study, testing whether thyroxine information transferred through a BICOM instrument slowed metamorphosis. Reports a difference from controls.
Category Archives: Scientific Studies
Scientific studies about Bicom therapies using Bicom 2000 and Bicom Optima
Kreisl, Erfahrungsheilkunde, 1998. A bench experiment: acetic acid information passed through an electronic amplifier into inorganic salt solutions, with pH measured against untreated solutions. Reports a small, amplification dependent fall in pH.
Sakharov and colleagues, Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, Kyiv. A seven month animal study of mice from the Chernobyl zone, comparing thymus and lymph node indices in treated and untreated groups against Kyiv controls. Reports partial normalisation in the treated group.
A prospective randomised study, translated from the German, of patients with slight liver cell damage: one group treated with endogenous electromagnetic fields through a BICOM device, one control, with liver enzymes (GOT, GPT, gamma GT) compared. Published in the Regumed compendium.
Islamov, Balabanova, Funtikov, Gotovskii and Meizerov, Bulletin of Experimental Biology and Medicine, 2002. Measures superoxide dismutase, catalase, glutathione peroxidase and reduced glutathione in lymphocytes from rheumatoid arthritis patients before and after bioresonance therapy. Translated from the Russian.
Sakharov, Waiserman, Koshel and Lednyiczky, National Academy of Sciences of Ukraine. A laboratory study exposing heat shocked Drosophila chrysalises to biological electromagnetic fields and recording viability against controls. Animal model, not a clinical study.
Fedorowski, Steciwko and Rabczynski. An animal study of low frequency electromagnetic stimulation in Buffalo rats carrying Morris hepatoma. Reports total tumour regression in 31 of 45 treated animals with histological verification, and no lung metastases in that group.
Pihtili and colleagues, Forschende Komplementärmedizin, 2014. A placebo controlled pilot of MORA bioresonance for smoking cessation in 190 smokers, with follow up at one week, two weeks, one month and one year. Reports 28.6 per cent abstinence at one year against 16.1 per cent for placebo.
Sümer, Gedik, Tunç and Özerkan, Cumhuriyet University, Sivas. An in vitro study applying bioresonance to MG-63 osteosarcoma cells in culture. Reports that proliferation was suppressed under the conditions of the experiment. Cell culture only, no patients.
Hans Brügemann, head of the Institute for Regulative Medicine, Gräfelfing. A congress talk on what level of evidence means and which BICOM studies reach which level, drawing on the Rahlfs appraisal. The manufacturer’s own account of its evidence base.